PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

miRNA dysregulation of AGE/RAGE pathway in metabolic syndrome: a novel analysis strategy utilizing miRNA-profiling data

2025-07-29
(Press-News.org) Metabolic Syndrome (MetS), characterized by abdominal obesity, hypertension, dyslipidemia, and insulin resistance, represents a global health crisis with escalating prevalence. Its comorbidities—including type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), atherosclerosis, and polycystic ovary syndrome (PCOS)—share underlying molecular pathways. Among these, the receptor for advanced glycation end products (RAGE) and its ligands (AGEs, HMGB1, S100 proteins) form the AGE/RAGE axis, a key driver of inflammation, oxidative stress, and tissue damage in MetS. While targeting this axis is a promising therapeutic strategy, the role of microRNAs (miRNAs) in its dysregulation remains poorly understood. This review systematically maps miRNA-mediated dysregulation of the AGE/RAGE pathway in MetS, employing a novel dual-method approach to overcome limitations of conventional literature reviews.

Methodology: Dual Analytical Approaches Inductive ("Bottom-Up") Approach:

A classical literature review identified miRNAs targeting core AGE/RAGE genes (HMGB1, AGER, scavenger receptors) in MetS comorbidities.

Searches used PubMed queries combining gene names, "miRNA," and pathology terms (e.g., "atherosclerosis").

Limitation: Data were sparse, heavily skewed toward atherosclerosis (14/19 studies), and neglected key receptors (e.g., AGER, anti-RAGEs) and ligands (S100s).

Deductive/Synthetic ("Top-Down") Approach:

Step 1: Identified differentially expressed miRNAs (DEMs) from microarray studies across MetS comorbidities (obesity, T2DM, NAFLD, atherosclerosis, PCOS, periodontitis) in pathology-relevant tissues (e.g., liver for NAFLD, subcutaneous adipose tissue (sWAT) for obesity).

Step 2: Mapped DEMs to experimentally verified targets in miRTarBase v9.0.

Step 3: Overlapped targets with an extended AGE/RAGE pathway gene set (from WikiPathways WP2324 + key receptors/ligands).

Innovation: Enabled ranking of comorbidities by degree of AGE/RAGE dysregulation and discovery of novel miRNA-pathway connections.

Key Findings Pathway Dysregulation Extends Beyond Atherosclerosis:

Atherosclerosis plaques showed the highest miRNA-AGE/RAGE dysregulation (64 DEMs, 284 miRNA-target interactions (MTIs)), followed by MetS in peripheral blood mononuclear cells (PBMCs) and obesity in sWAT.

Significant dysregulation was also confirmed in immune cells (PBMCs) and adipose tissue, broadening the focus beyond vascular pathology.

Novel Multi-Pathology miRNAs:

miR-92a-3p (downregulated in obesity/sWAT, atherosclerosis, PCOS) targeted 13 AGE/RAGE genes (ADAM10, HMGB1, NFKB1), potentially linking adipose dysfunction, vascular injury, and PCOS.

miR-34a-5p (upregulated in PBMCs and plaques) regulated 15 pathway genes (HMGB1, NFKB1, STAT1) and promotes inflammation.

miR-145-5p/miR-143-3p (downregulated in obesity/sWAT and insulin resistance) jointly targeted 19 genes (AKT1, CD36, STAT3), implicating AGE/RAGE in adipose insulin signaling.

Critical Knowledge Gaps:

Core receptors (AGER, DDOST) and ligands (S100A6, S100A12, S100P) had <10 experimentally verified MTIs in databases, hindering analysis.

AGER itself had only 3 known MTIs, yet 67% were dysregulated in MetS comorbidities, underscoring its understudied role.

Validation Across Approaches:

8 miRNAs (e.g., miR-126-3p, miR-185-5p, let-7g-5p) identified via the inductive approach were validated as DEMs in the deductive analysis, confirming their roles in AGE/RAGE dysregulation across pathologies.

Clinical and Therapeutic Implications Diagnostic Potential: DEMs like miR-92a-3p may serve as multi-comorbidity biomarkers.

Therapeutic Targets:

miR-145-5p overexpression reduced atherosclerosis in mice.

miR-34a-5p inhibition improved NAFLD in animal models.

miR-92a-3p antagonism attenuated atherosclerosis and reduced androgen synthesis in PCOS models.

Caveat: No studies directly link miRNA therapies to AGE/RAGE modulation in MetS, highlighting a research gap.

Conclusion This review pioneers a synthetic strategy integrating miRNA profiling with pathway analysis, revealing widespread but understudied miRNA dysregulation of the AGE/RAGE axis in MetS. While atherosclerosis remains the best-characterized comorbidity, the approach uncovers significant dysregulation in adipose tissue, liver, and immune cells. Prioritizing poorly studied receptors (e.g., AGER, anti-RAGEs) and multi-pathology miRNAs (e.g., miR-92a-3p) could accelerate targeted therapies for MetS and its comorbidities.

 

Full text

https://www.xiahepublishing.com/1555-3884/GE-2025-00039

 

The study was recently published in the Gene Expression.

Gene Expression (GE) is an open-access journal. It was launched in 1991 by Chicago Medical School Press, and transferred to Cognizant Communication Corporation in 1994. From August 2022, GE is published by Xia & He Publishing Inc.   

GE publishes peer-reviewed and high-quality original articles, reviews, editorials, commentaries, and opinions on its primary research topics including cell biology, molecular biology, genes, and genetics, especially on the cellular and molecular mechanisms of human diseases. 

GE has been indexed in Medline (1991-2021), Scopus, Biological Abstracts, Biosis Previews, ProQuest, etc.

 

Follow us on X: @xiahepublishing

Follow us on LinkedIn: Xia & He Publishing Inc.

END



ELSE PRESS RELEASES FROM THIS DATE:

AI catches one-third of interval breast cancers missed at screening

2025-07-29
OAK BROOK, Ill. – An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published today in Radiology, a journal of the Radiological Society of North America (RSNA).   Interval breast cancers—symptomatic cancers diagnosed within a period between regular screening mammography exams—tend to have poorer outcomes due to their more aggressive biology and rapid growth. DBT, or 3D mammography, can improve visualization of breast lesions and reveal cancers that may be obscured by dense tissue. Because DBT is ...

Researchers advocate for separate roles between AI and humans

2025-07-29
OAK BROOK, Ill. – Renowned physician-scientist Eric J. Topol, M.D., and Harvard artificial intelligence (AI) expert Pranav Rajpurkar, Ph.D., advocate for a clear separation of the roles between AI systems and radiologists in an editorial published today in Radiology, a journal of the Radiological Society of North America (RSNA). “We’re stuck between distrust and dependence, and missing out on the full potential of AI,” said Dr. Rajpurkar, associate professor of Biomedical Informatics at Harvard University. The ...

SwRI expands antenna testing capabilities with spherical near-field range

2025-07-29
SAN ANTONIO — July 29, 2025 — Southwest Research Institute (SwRI) is expanding its antenna measurement capabilities with a state-of-the-art spherical near-field antenna range. The 1,260-square-foot indoor range, lined with radio frequency and microwave foam absorbers, is equipped to accurately sample the near field of an antenna. Near-field measurements can be mathematically transformed into far-field data. “Near field” refers to the complex electromagnetic fields close to the antenna, while the “far field” encompasses the predictable ...

The complex relationship between fusion fuel and lithium walls

2025-07-29
Lithium is considered a key ingredient in the future commercial fusion power plants known as tokamaks, and there are several ways to use this metal to enhance the process. But a key question remained: How much does it impact the amount of fuel trapped in the walls of tokamaks? According to new research from a global collaboration spanning nine institutions, the dominant driver of fuel retention is co-deposition: a process where fuel is trapped alongside lithium. Co-deposition can happen with lithium that is directly added during plasma operations, ...

Study refutes blood thinner brain bleed risk after falls in older adults

2025-07-29
There are about 70 million baby boomers in the United States, many now over age 65. As people age, rates of cardiovascular and cerebrovascular diseases rise, leading to more use of blood thinners such as warfarin. At the same time, older adults face a higher risk of head injuries and brain bleeding, especially after falls. Falls are the leading cause of injury and death in older adults, causing 38,000 deaths and 3 million emergency department visits in 2021. The health care cost for non-fatal falls in this group reached $80 billion in 2020, up sharply from 2015. While anticoagulants protect against heart and ...

"Breakthrough in progeria therapy: RNA scissors precisely target and remove mutant gene"

2025-07-29
Children who develop deep wrinkles, stunted growth, and rapidly aging bones and blood vessels as early as 1 to 2 years of age may be suffering from Hutchinson-Gilford Progeria Syndrome (HGPS), a rare and incurable genetic disorder that affects approximately one in eight million people. The average life expectancy for patients is just 14.5 years, and to date, no curative treatment exists. The only FDA-approved drug for progeria, lonafarnib (Zokinvy), comes at an extraordinary cost—approximately 1.4 billion ...

The Mount Sinai Hospital ranked among top in the nation by US News & World Report®

2025-07-29
FOR IMMEDIATE RELEASE Contact:   Dan Verello Mount Sinai Press Office 212-241-9200 daniel.verello@mountsinai.org The Mount Sinai Hospital Ranked Among Top in the Nation by U.S. News & World Report® Five specialties ranked among Top 10; nine among Top 20 Mount Sinai West and Mount Sinai Morningside nationally ranked in 5 specialties New York, NY (July 29, 2025) – The Mount Sinai Hospital, the flagship hospital of Mount Sinai Health System, was listed among the nation’s top 20 hospitals for care excellence by U.S. News & World Report® for 2025-26, marking the 10th consecutive year the hospital has been listed on the publication’s “Honor ...

Storage process: a new method reduces the acute toxicity of the essential oil of Artemisia argyi H. Lév. & Vaniot by 40%

2025-07-29
Background and objectives Artemisia argyi H. Lév. & Vaniot essential oil (AAEO) holds significant pharmacological potential, but its application is constrained by hepatotoxicity. This study aimed to investigate the feasibility of reducing AAEO’s toxicity through storage and to evaluate changes in chemical composition, toxicity, and bioactivity. Methods Gas chromatography-mass spectrometry was used to analyze compositional changes during storage. Zebrafish acute toxicity tests and the liver-specific transgenic zebrafish model ...

Licensed to live

2025-07-29
The DNA packed inside every human cell contains instructions for life, written in billions of letters of genetic code. Every time a cell divides, the complete code, divided among 46 chromosomes, must be faithfully copied. This staggering task happens over and over with extraordinary precision. Decades of research have revealed how dozens of proteins work together to copy chromosomes reliably. Now, Cold Spring Harbor Laboratory (CSHL) President Bruce Stillman and colleagues have compiled these findings into a comprehensive view of the very first step: a “licensing” ...

How to survive the explosion of AI slop

2025-07-29
In a Perspective, Hany Farid highlights the risk of manipulated and fraudulent images and videos, known as deepfakes, and explores interventions that could mitigate the harms deepfakes can cause. Farid explains that visually discriminating the real from the fake has become increasingly difficult and summarizes his research on digital forensic techniques, used to determine whether images and videos have been manipulated. Farid celebrates the positive uses of generative AI, including helping researchers, democratizing content creation, and, in some cases, literally giving voice ...

LAST 30 PRESS RELEASES:

Tiny 3D printer reconstructs tissues during vocal cord surgery

New genetic marker found to predict severe gout drug reactions in US patients

Schizophrenia, bipolar, or major depressive disorder and postacute sequelae of COVID-19

Fruit flies offer new insights into how human Alzheimer’s Disease risk genes affect the brain

University of Phoenix College of Doctoral Studies releases white paper on mentoring programs to strengthen worker autonomy and competitive edge

International scientists issue State of the Climate Report, highlight mitigation strategies

“State of the climate” 2025: Earth’s vital signs worsen, science shows options for livable future

New nanomedicine wipes out leukemia in animal study

National TRAP Program targets ghostly issue with second round of coastal clean up funding

Six scientists receive AFAR grants for junior faculty

Climate report: Earth on dangerous path but rapid action can avert the worst outcomes

American Pediatric Society announces Bruce D. Gelb, MD, as recipient of its prestigious 2026 APS John Howland Award

Friendships can ease loneliness for dementia caregivers

Researchers pose five guiding questions to improve the use of artificial intelligence in physicians’ clinical decision-making

Global call to “Help the Kelp” with US $14 billion conservation target

Artificial tongue uses milk to determine heat level in spicy foods

IU Kelley Futurecast: AI and energy infrastructure may buoy US economy in 2026

The biggest threats to maintaining fat bike trails: climate change and volunteer burnout

AI models for drug design fail in physics

Practice pattern of aerosol drug therapy in acute respiratory distress syndrome patients: An aero-in-ICU study

GLIS model as a predictor of outcomes in older adults with heart failure

Molecules in motion: pioneering the era of supramolecular robotics

Faster and more reliable crystal structure prediction of organic molecules

Thankful at work: A two-week gratitude journal boosts employee engagement

Fibroblasts: Hidden drivers of heart failure progression

IOCB Prague unveils a fundamentally faster, more affordable way to produce quantum nanodiamonds

Artificial intelligence takes the lead in revolutionizing cancer research explored at NFCR’s 2025 Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship.

Switching memories on and off with epigenetics

This is your brain without sleep

3D DNA looping discovery in rice paves the way for higher yields with less fertilizer

[Press-News.org] miRNA dysregulation of AGE/RAGE pathway in metabolic syndrome: a novel analysis strategy utilizing miRNA-profiling data